A Retrospective Single-Center Review of Primary Sclerosing Cholangitis in Children

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 2, 2009, Pages 239-245

  Miloh, Tamir ^a   Arnon, Ronen ^a   Shneider, Benjamin ^b   Suchy, Frederick ^a   Kerkar, Nanda ^a  

^a Recanati/Miller Transplantation Institute   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; METHOTREXATE; STEROID; URSODEOXYCHOLIC ACID;

ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; BILE DUCT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COLON; COLONOSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER LEVEL; LIVER TRANSPLANTATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; MEDICAL RECORD REVIEW; RECTUM; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS; SURVIVAL RATE; SYMPTOM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOLAGOGUES AND CHOLERETICS; CHOLANGIOGRAPHY; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID; YOUNG ADULT;

EID: 58849148044     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.10.019     Document Type: Article

References (29)

1. Vergani D., and Mieli-Vergani G. Autoimmune hepatitis and PSC connection. Clin Liver Dis 12 (2008) 187-202
2. Kaplan G.G., Laupland K.B., Butzner D., et al. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol 102 (2007) 1042-1049
3. Mendes F.D., Jorgensen R., Keach J., et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 101 (2006) 2070-2075
4. LaRusso N.F., Shneider B.L., Black D., et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology 44 (2006) 746-764
5. Angulo P., Maor-Kendler Y., and Lindor K.D. Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 35 (2002) 1494-1500
6. el-Shabrawi M., Wilkinson M.L., Portmann B., et al. Primary sclerosing cholangitis in childhood. Gastroenterology 92 (1987) 1226-1235
7. Wilschanski M., Chait P., Wade J.A., et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 22 (1995) 1415-1422
8. Floreani A., Zancan L., Melis A., et al. Primary sclerosing cholangitis (PSC): clinical, laboratory and survival analysis in children and adults. Liver 19 (1999) 228-233
9. Debray D., Pariente D., Urvoas E., et al. Sclerosing cholangitis in children. J Pediatr 124 (1994) 49-56
10. Feldstein A.E., Perrault J., El-Youssif M., et al. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 38 (2003) 210-217
11. Gregorio G.V., Portmann B., Karani J., et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33 (2001) 544-553
12. Rudolph G., Kloeters-Plachky P., Rost D., et al. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid. Eur J Gastroenterol Hepatol 19 (2007) 487-491
13. Pardi D.S., Loftus Jr. E.V., Kremers W.K., et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 124 (2003) 889-893
14. Lindor K.D. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N Engl J Med 336 (1997) 691-695
15. Charatcharoenwitthaya P., Angulo P., Enders F.B., et al. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis. Hepatology 47 (2007) 133-142
16. Olsson R., Boberg K.M., de Muckadell O.S., et al. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 129 (2005) 1464-1472
17. Alvarez F., Berg P.A., Bianchi F.B., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
18. Tischendorf J.J., Hecker H., Kruger M., et al. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 102 (2007) 107-114
19. Floreani A., Rizzotto E.R., Ferrara F., et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 100 (2005) 1516-1522
20. van Buuren H.R., van Hoogstraten H.J.E., Terkivatan T., et al. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 33 (2000) 543-548
21. Abdalian R., Dhar P., Jhaveri K., et al. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging. Hepatology 47 (2007) 949-957
22. Charatcharoenwitthaya P., Angulo P., Enders F.B., et al. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis. Hepatology 47 (2008) 133-142
23. Tischendorf J.J., Geier A., and Trautwein C. Current diagnosis and management of primary sclerosing cholangitis. Liver Transpl 14 (2008) 735-746
24. Burak K.W., Angulo P., and Lindor K.D. Is there a role for liver biopsy in primary sclerosing cholangitis?. Am J Gastroenterol 98 (2003) 1155-1158
25. Batres L.A., Russo P., Mathews M., et al. Primary sclerosing cholangitis in children: a histologic follow-up study. Pediatr Dev Pathol 8 (2005) 568-576
26. Berstad A.E., Aabakken L., Smith H.J., et al. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. Clin Gastroenterol Hepatol 4 (2006) 514-520
27. McDiarmid S.V., and Anand R. Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 Annual Report. Clin Transpl (2003) 119-130
28. Cholongitas E., Shusang V., Papatheodoridis G.V., et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 14 (2008) 138-143
29. Alexander J., Lord J.D., Yeh M.M., et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 14 (2008) 245-251